| CTRI Number |
CTRI/2024/09/074075 [Registered on: 19/09/2024] Trial Registered Prospectively |
| Last Modified On: |
19/12/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A clinical trial to compare the efficacy of two different drugs in peribulbar block in patients undergoing small incision cataract surgery. |
|
Scientific Title of Study
|
Efficacy of peribulbar block with the combination of 2 percent lidocaine and 0.75 percent ropivacaine versus 2 percent lidocaine and 0.5 percent bupivacaine in cataract surgery ; a randomised controlled trial. |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Prajakta Mehare |
| Designation |
Junior Resident |
| Affiliation |
NKP Salve institute of medical sciences |
| Address |
Atul Kirana Shop, Main Road, Borgaon Manju, Taluka District Akola
Akola MAHARASHTRA 444102 India |
| Phone |
7499036449 |
| Fax |
|
| Email |
mehareprajakta@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Sumita Bhargava |
| Designation |
Associate professor |
| Affiliation |
NKP Salve institute of medical sciences |
| Address |
Department of Anaesthesiology, fourth floor, NKP Salve institute of medical sciences and research centre and LMH hospital, Digdoh hills, Hingna road, Nagpur
MAHARASHTRA
440019
India
MAHARASHTRA 440019 India |
| Phone |
7219105329 |
| Fax |
|
| Email |
bhargavasumita@yahoo.in |
|
Details of Contact Person Public Query
|
| Name |
Prajakta Mehare |
| Designation |
junior resident |
| Affiliation |
NKP Salve institute of medical sciences |
| Address |
Department of Anaesthesiology, NKP Salve institute of medical sciences and research centre and LMH hospital, Digdoh hills, Hingna road, Nagpur
MAHARASHTRA
440019
India
Nagpur MAHARASHTRA 440019 India |
| Phone |
7499036449 |
| Fax |
|
| Email |
mehareprajakta@gmail.com |
|
|
Source of Monetary or Material Support
|
| NKP SALVE institute of medical sciences and Lata Mangeshkar hospital, Digdoh hills, Hingna road, Nagpur
|
|
|
Primary Sponsor
|
| Name |
NKP Salve institute of medical sciences and research centre and LMH hospital Nagpur |
| Address |
Digdoh hills, Hingna road, Nagpur, Maharashtra,India 440019
|
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Prajakta Mehare |
Lata Mangeshkar hospital Nagpur |
Department of Anaesthesiology, NKP Salve institute of medical sciences and research centre Digdoh hills, Hingna road, Nagpur
Nagpur
MAHARASHTRA Nagpur MAHARASHTRA |
7499036449
mehareprajakta@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| NKP SALVE institute of medical sciences and RC nd Lata Mangeshkar Hospital , Nagpur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: H25||Age-related cataract, (2) ICD-10 Condition: H28||Cataract in diseases classified elsewhere, (3) ICD-10 Condition: H26||Other cataract, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
lidocaine with bupivacaine and hyaluronidase |
2% lidocaine 4ml with 0.5% bupivacaine 4ml and 15IU/ml of Hyaluronidase will be administered as an anaesthetic agent in the peribulbar block given to patients undergoing small incision cataract surgery. |
| Intervention |
lidocaine with ropivacine and Hyaluronidase |
2 % lidocaine with 0.75% ropivacine and 15 IU/ml of Hyaluronidase will be administered as an anaesthetic agent in the peribulbar block given to patients undergoing small incision cataract surgery. |
|
|
Inclusion Criteria
|
| Age From |
40.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
1} patients of ASA 1 and 2
2} patients posted for small incision cataract surgery |
|
| ExclusionCriteria |
| Details |
1} patients having local sepsis, glaucoma, coagulation abnormality.
2} patient refusal
3} uncooperative patient |
|
|
Method of Generating Random Sequence
|
Permuted block randomization, fixed |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
To compare efficacy of combination of 2% lidocaine with 0.75% ropivacaine and 2% lidocaine with 0.5% bupivacaine for peribulbar block in patients undergoing cataract surgery with respect to :
1} onset of sensory blockade {in minutes}
2}onset of motor blockade {in minutes}
3} duration of post operative analgesia {in minutes} |
1)Post operative pain assessment will be done every half hour for 2 hours and hourly for 6 hours.
2)24 hrs analgesic requirement will be noted |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To compare the combination of 2% lidocaine with 0.75% ropivacaine & 2% lidocaine with 0.5% bupivacaine in patients undergoing cataract surgery under peribulbar block with respect to :
1} hemodynamic stability
2} side effects- nausea, vomiting |
1} hemodynamic stability - systolic blood pressure
diastolic blood pressure
mean arterial blood pressure
heart rate
oxygen saturation
electrocardiogram
will be observed from the application of peribulbar block till the end of procedure.
2}side effects- nausea, vomiting will be observed from the application of peribulbar block till the end of procedure.
Time of block will be taken as 0 min & patient will be observered at 5 min intervals till end of procedure. |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
30/09/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="11" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is a randomised, double blind study to compare the effectiveness of two different drug combinations - 2% lidocaine with 0.75% ropivacaine and 2% lidocaine with 0.5% bupivacaine - in terms of duration of sensory blockade, motor blockade and post operative analgesia in patients undergoing small incision cataract surgery. Either of the drug combinatons depending on the study group, will be used as an anaesthetic agent of induction for peribulbar block in a total of 80 patients, divided into groups of 40 each and suffering from various types of cataract. This study will be conducted in the department of Anaesthesia at a tertiary care centre in Nagpur. The hemodynamic stability in terms of heart rate, systolic ,diastolic and mean arterial blood pressure , oxygen saturation along with side effects like nausea and vomitiing will be monitored from the time of application of the block till the end of procedure. |